Neural Cell Differentiation With Cryopreserved PSC Expansion

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for differentiating pluripotent stem cells (PSCs) into neurons are inefficient, time-consuming, and unsatisfactory for high-throughput assays, leading to a bottleneck in neurological studies due to the need for continuous preparation and low yield of mature neural cells.

Innovation Solution

Methods for cryopreserving and expanding billions of PSCs and neural cells at an industrial scale, allowing on-demand production of differentiated neural cells with enhanced yield and maturity, using techniques such as forced expression of transcription factors and optogenetic constructs, and incorporating automation for consistent results.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing differentiation methods are used, then neural cells can be produced, but the process takes months and has low yield

Engineering Contradiction:

Improveproduction speed of neural cellsVSAvoidtime required for differentiation process

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The patent changes the biochemical parameters of the differentiation process by using defined small molecules (such as retinoic acid, dorsomorphin, and SB431542) to control stem cell fate. This chemical parameter control accelerates differentiation compared to traditional undefined serum-based methods, reducing the time required while maintaining high yield of mature neural cells.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary expansion and characterization of stem cell lines before differentiation. By pre-expanding large numbers of stem cells and cryopreserving them, the actual differentiation process can be initiated quickly when needed, eliminating the need to start from scratch each time neural cells are required for assays.

Inventive Principle:

Principle #10Preliminary action

2Reliability

If continuous preparation of PSCs is performed, then neural cells are available for assays, but costs and resource usage increase

Engineering Contradiction:

Improveavailability of neural cells for assaysVSAvoidresource consumption and production costs

Core Design Contradiction:

ReliabilityVSLoss of energy

Solution Approach 1:

The patent implements preliminary expansion and cryopreservation of large numbers of stem cells and differentiated neural cells. This allows cells to be prepared in advance, stored, and readily deployed for assays without continuous production cycles, significantly reducing resource consumption and costs while ensuring reliable availability.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent creates multiple copies of stem cell lines and differentiated neural cell populations through expansion cultures. These cell copies can be cryopreserved and thawed as needed, eliminating the need for continuous de novo differentiation and reducing overall resource requirements.

Inventive Principle:

Principle #26Copying

3Quantity of substance

If existing differentiation techniques are used, then some neural cells are produced, but they have limited ability to form synapses and show inconsistent results

Engineering Contradiction:

Improveyield of neural cellsVSAvoidconsistency and quality of neural cell maturation

Core Design Contradiction:

Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent uses defined small molecule concentrations and combinations to precisely control differentiation parameters. This leads to consistent production of mature, synaptically competent neural cells with reproducible results across experiments, overcoming the variability inherent in traditional methods.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent incorporates monitoring of differentiation markers and cellular morphology to assess maturation progress. This feedback allows optimization of differentiation conditions to ensure consistent production of functionally mature neural cells capable of forming synapses and showing reproducible assay results.

Inventive Principle:

Principle #23Feedback

4Productivity

If PSCs are cryopreserved and expanded, then industrial scale production is achieved, but process complexity increases

Engineering Contradiction:

Improvethroughput of neural cell productionVSAvoidcomplexity of cryopreservation and expansion infrastructure

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent develops a universal platform using defined small molecules that can differentiate multiple types of neural cells (cortical neurons, dopaminergic neurons, motor neurons) from a single stem cell line. This multi-functionality reduces the need for separate specialized protocols and infrastructure for each cell type, managing complexity while maintaining high throughput.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS12577529B2Methods for producing neural cells

Publication Date: 2026.03.17 QUIVER HOLDINGS INC

AI summary

The present invention provides differentiated neural cells and methods for making differentiated neural cells from pluripotent stem cells (PSC) at an industrial scale sufficient for high-throughput assays. The methods of the invention allow billions of PSCs and/or neural cells differentiated from the PSCs to be cryopreserved and expanded at multiple steps.